916213-93-9 Usage
General Description
Tert-butyl (3-cyanobenzyl)carbamate is a chemical compound that is also known by its chemical formula C14H18N2O2. It is a carbamate derivative with a tert-butyl group and a 3-cyanobenzyl group attached to the carbonyl carbon. tert - butyl (3 - cyanobenzyl)carbaMate has potential applications in the pharmaceutical industry, specifically as an intermediate in the synthesis of various drugs. It is also used in research and development as a building block for the creation of new molecules with potentially valuable properties. Tert-butyl (3-cyanobenzyl)carbamate may also have uses as an insecticide or in other industrial applications. Due to its specific chemical structure and properties, it is important to handle this compound with care and follow proper safety precautions when working with it.
Check Digit Verification of cas no
The CAS Registry Mumber 916213-93-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,6,2,1 and 3 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 916213-93:
(8*9)+(7*1)+(6*6)+(5*2)+(4*1)+(3*3)+(2*9)+(1*3)=159
159 % 10 = 9
So 916213-93-9 is a valid CAS Registry Number.
916213-93-9Relevant articles and documents
One-pot synthesis of α-amino acids from CO2 using a bismetal reagent with Si-B bond
Mita, Tsuyoshi,Chen, Jianyang,Sugawara, Masumi,Sato, Yoshihiro
, p. 6202 - 6205 (2013/02/23)
In the presence of 1.1 equiv of PhMe2Si-Bpin, 5 equiv of CsF, and 20 mol % of TsOH·H2O, precursors of N-Boc-imines can be converted into the corresponding α-aryl or α-alkenyl glycine derivatives under gaseous CO2 in moderate-to-high yields with a single operation. α-Isobutenyl glycine thus obtained can be further derivatized into various types of α-amino acids including N-Boc-leucine, serine, and glycine derivatives in short steps.
(3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING
-
Page/Page column 117-118, (2009/05/29)
The present invention provides novel beta-secretase inhibitors and methods for their use, including methods of treating of Alzheimer's disease. (Formula)
